CLINICAL_TRIALS
trial_result
· 2022-09-22
Clinical Trial Update: Arista for ALT Donor Sites to Reduce Drain Output [NA]
Summary
A completed clinical trial evaluating Arista for ALT donor sites to reduce drain output in seroma management; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Seroma | NA | Status: COMPLETED | Results posted: 2022-09-22